Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common stock, $.01 par value per share
-
Shares outstanding
-
46,791,479
-
Total 13F shares
-
54,173,562
-
Share change
-
-445,145
-
Total reported value
-
$1,765,475,443
-
Put/Call ratio
-
326%
-
Price per share
-
$32.59
-
Number of holders
-
187
-
Value change
-
-$102,994,220
-
Number of buys
-
97
-
Number of sells
-
98
Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q1 2014
As of 31 Mar 2014,
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,173,562 shares.
The largest 10 holders included
Neuberger Berman Group LLC, VANGUARD GROUP INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Fund Advisors, FMR LLC, PRUDENTIAL PLC, BlackRock Institutional Trust Company, N.A., Van Berkom & Associates Inc., SNYDER CAPITAL MANAGEMENT L P, and Camber Capital Management LLC.
This page lists
187
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.